Clinical Trial Update: Inflammation Markers Over Time in Cardiovascular Disease

View source ↗

Summary

NHLBI-sponsored clinical trial evaluating inflammation markers over time in cardiovascular disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases
• Coronary Artery Disease
• Heart Disease
• Thrombosis

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Cardiovascular Diseases, Coronary Disease | Status: COMPLETED